SMTL ID : 6ccy.1

Crystal structure of Akt1 in complex with a selective inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.18 Å

Oligo State

monomer

Ligands

1 x EX4: (5R)-4-(4-{4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-[2-(pyrrolidin-1-yl)ethyl]-1H-imidazol-2-yl}piperidin-1-yl)-5-methyl-5,8-dihydropyrido[2,3-d]pyrimidin-7(6H)-one(Non-covalent)

EX4.1: 22 residues within 4Å: Chain A: L.16, G.17, K.18, G.19, T.20, F.21, G.22, K.23, V.24, A.37, K.39, L.41, T.71, M.87, E.88, Y.89, A.90, E.94, E.138, M.141, F.298, F.302 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.16, A:V.24, A:E.138 Hydrogen bonds: A:E.88, A:A.90 Salt bridges: A:E.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Parthasarathy, S. et al., Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT. Bioorg. Med. Chem. Lett. (2018)

Release Date

2018-05-02

Peptides

RAC-alpha serine/threonine-protein kinase,PIFtide: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RAC-alpha serine/threonine-protein kinase,PIFtide